arrow
P

Paolo Matteucci

University of Hull
H指数:14
被引数:1,126

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Importance of the timing of combined electrochemotherapy and immunotherapy in the treatment of advanced melanoma

联合电化学疗法和免疫疗法治疗晚期黑色素瘤时,治疗时机的意义

2025-11-210
PRE
European e-Delphi process to define expert consensus on electrochemotherapy treatment indications, procedural aspects, and quality indicators in melanoma
2023-05-033
OA
Electrochemotherapy for the treatment of cutaneous squamous cell carcinoma: The INSPECT experience (2008-2020)
2022-09-2017
OAAI
Prospective cohort study by InspECT on safety and efficacy of electrochemotherapy for cutaneous tumors and metastases depending on ulceration
2022-04-058
PRE
Immunotherapy in association with stereotactic radiotherapy for non-small cell lung cancer brain metastases: results from a multicentric retrospective study on behalf of AIRO

免疫疗法联合立体定向放射治疗非小细胞肺癌脑转移: 代表AIRO的多中心回顾性研究结果

2021-05-2945
OA
Outcomes of older adults aged 90 and over with cutaneous malignancies after electrochemotherapy with bleomycin: A matched cohort analysis from the InspECT registry

90岁及以上患有皮肤恶性肿瘤的老年人在接受博来霉素电化学治疗后的结果: 来自InspECT registry的匹配队列分析

EJSO
IF2.9
2021-04-0118
PREAI
Electrochemotherapy in the treatment of cutaneous malignancy: Outcomes and subgroup analysis from the cumulative results from the pan-European International Network for Sharing Practice in Electrochemotherapy database for 2482 lesions in 987 patients (2008-2019)
2020-10-0173
PREAI
1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility Study (vol 25, pg 2541, 2018)
2018-06-261
OA
1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility Study
2018-05-3036
OAAI